La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
NuVasive Gestione
Gestione criteri di controllo 3/4
NuVasive's CEO is Chris Barry, appointed in Nov 2018, has a tenure of 4.83 years. total yearly compensation is $8.08M, comprised of 11.1% salary and 88.9% bonuses, including company stock and options. directly owns 0.14% of the company’s shares, worth $2.90M. The average tenure of the management team and the board of directors is 3.7 years and 5.6 years respectively.
Informazioni chiave
Chris Barry
Amministratore delegato
US$8.1m
Compenso totale
| Percentuale dello stipendio del CEO | 11.1% |
| Mandato del CEO | 4.8yrs |
| Proprietà del CEO | 0.1% |
| Durata media del management | 3.7yrs |
| Durata media del Consiglio di amministrazione | 5.6yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Is NuVasive (NASDAQ:NUVA) Using Too Much Debt?
Apr 18
What Does NuVasive, Inc.'s (NASDAQ:NUVA) Share Price Indicate?
Jan 24NuVasive, Inc.'s (NASDAQ:NUVA) Intrinsic Value Is Potentially 48% Above Its Share Price
Dec 31Capital Allocation Trends At NuVasive (NASDAQ:NUVA) Aren't Ideal
Dec 05These 4 Measures Indicate That NuVasive (NASDAQ:NUVA) Is Using Debt Reasonably Well
Nov 13Calculating The Intrinsic Value Of NuVasive, Inc. (NASDAQ:NUVA)
Sep 22Capital Allocation Trends At NuVasive (NASDAQ:NUVA) Aren't Ideal
Sep 01NuVasive Likely Undervalued, But It's Hard To Find Catalysts
Aug 17Does NuVasive (NASDAQ:NUVA) Have A Healthy Balance Sheet?
Aug 11NuVasive Non-GAAP EPS of $0.47 misses by $0.09, revenue of $310.5M beats by $4.12M
Aug 03NuVasive: Industry Tailwinds More Than Fairly Priced
Jun 13Calculating The Intrinsic Value Of NuVasive, Inc. (NASDAQ:NUVA)
Jun 01Investors Could Be Concerned With NuVasive's (NASDAQ:NUVA) Returns On Capital
May 11NuVasive (NASDAQ:NUVA) Has A Pretty Healthy Balance Sheet
Apr 20At US$56.32, Is NuVasive, Inc. (NASDAQ:NUVA) Worth Looking At Closely?
Mar 30NuVasive's Turnaround Story Needs A Boost From Better Results
Mar 01Investors Could Be Concerned With NuVasive's (NASDAQ:NUVA) Returns On Capital
Dec 28Should You Think About Buying NuVasive, Inc. (NASDAQ:NUVA) Now?
Dec 02NuVasive (NASDAQ:NUVA) Has A Pretty Healthy Balance Sheet
Nov 11NuVasive, Inc. (NASDAQ:NUVA) Shares Could Be 32% Below Their Intrinsic Value Estimate
Oct 21Be Wary Of NuVasive (NASDAQ:NUVA) And Its Returns On Capital
Sep 29At US$59.79, Is It Time To Put NuVasive, Inc. (NASDAQ:NUVA) On Your Watch List?
Aug 18NuVasive Still Getting No Love With COVID-19 And Competitive Worries
Aug 12Does NuVasive (NASDAQ:NUVA) Have A Healthy Balance Sheet?
Jul 27Are Investors Undervaluing NuVasive, Inc. (NASDAQ:NUVA) By 21%?
Jun 17Some Investors May Be Worried About NuVasive's (NASDAQ:NUVA) Returns On Capital
May 30Why We Think NuVasive, Inc.'s (NASDAQ:NUVA) CEO Compensation Is Not Excessive At All
May 12Is NuVasive (NASDAQ:NUVA) Using Too Much Debt?
Mar 30Is Now The Time To Look At Buying NuVasive, Inc. (NASDAQ:NUVA)?
Mar 09Need To Know: NuVasive, Inc. (NASDAQ:NUVA) Insiders Have Been Buying Shares
Feb 16
A Look At The Fair Value Of NuVasive, Inc. (NASDAQ:NUVA)
Jan 26NuVasive stock gains on study results of its X360 surgery approach
Jan 06What Type Of Returns Would NuVasive's(NASDAQ:NUVA) Shareholders Have Earned If They Purchased Their SharesYear Ago?
Jan 05Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Jun 30 2023 | n/a | n/a | US$28m |
| Mar 31 2023 | n/a | n/a | US$20m |
| Dec 31 2022 | US$8m | US$897k | US$40m |
| Sep 30 2022 | n/a | n/a | -US$20m |
| Jun 30 2022 | n/a | n/a | -US$40m |
| Mar 31 2022 | n/a | n/a | -US$37m |
| Dec 31 2021 | US$8m | US$875k | -US$64m |
| Sep 30 2021 | n/a | n/a | -US$26m |
| Jun 30 2021 | n/a | n/a | US$2m |
| Mar 31 2021 | n/a | n/a | -US$50m |
| Dec 31 2020 | US$5m | US$735k | -US$37m |
| Sep 30 2020 | n/a | n/a | -US$9m |
| Jun 30 2020 | n/a | n/a | -US$4m |
| Mar 31 2020 | n/a | n/a | US$61m |
| Dec 31 2019 | US$5m | US$800k | US$65m |
| Sep 30 2019 | n/a | n/a | US$48m |
| Jun 30 2019 | n/a | n/a | US$52m |
| Mar 31 2019 | n/a | n/a | US$49m |
| Dec 31 2018 | US$5m | US$92k | US$12m |
Compensazione vs Mercato: Chris's total compensation ($USD8.08M) is above average for companies of similar size in the US market ($USD5.11M).
Compensazione vs guadagni: Chris's compensation has been consistent with company performance over the past year.
AMMINISTRATORE DELEGATO
Chris Barry (50 yo)
4.8yrs
Mandato
US$8,077,095
Compensazione
Mr. J. Christopher Barry, also known as Chris, serves as Chief Executive Officer and Director of NuVasive, Inc., since November 5, 2018. Mr. Barry served commercial and leadership roles at Covidien. He has...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| CEO & Director | 4.8yrs | US$8.08m | 0.14% $ 2.9m | |
| Principal Accounting Officer | 3.7yrs | US$2.97m | 0.020% $ 418.2k | |
| Senior Vice President of Global Operations | 3.7yrs | US$1.48m | 0.017% $ 355.5k | |
| Senior VP | 5.3yrs | US$1.54m | 0.042% $ 869.2k | |
| Senior Vice President of People & Culture | less than a year | US$1.03m | 0.0059% $ 123.8k | |
| Senior VP & Chief Technology Officer | 2yrs | Nessun dato | Nessun dato | |
| Vice President of Investor Relations | no data | Nessun dato | Nessun dato | |
| Senior Vice President of Strategy & Corporate Development | 3.8yrs | Nessun dato | Nessun dato | |
| Vice President & Head of Global Commercial Finance | 5.3yrs | Nessun dato | Nessun dato | |
| Senior Vice President of Information Technology | 1.7yrs | Nessun dato | Nessun dato | |
| Vice President | 5.3yrs | Nessun dato | Nessun dato |
3.7yrs
Durata media
48yo
Età media
Gestione esperta: NUVA's management team is considered experienced (3.7 years average tenure).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| CEO & Director | 4.8yrs | US$8.08m | 0.14% $ 2.9m | |
| Independent Director | 5.6yrs | US$260.01k | 0% $ 0 | |
| Independent Director | 7.6yrs | US$260.01k | 0% $ 0 | |
| Independent Director | 8.3yrs | US$280.01k | 0.0038% $ 79.4k | |
| Independent Director | 4.9yrs | US$260.01k | 0.0026% $ 54.0k | |
| Independent Chair | 8.2yrs | US$405.01k | 0% $ 0 | |
| Independent Director | 9.3yrs | US$270.01k | 0.0059% $ 123.0k | |
| Independent Director | 2.6yrs | US$260.01k | 0.0071% $ 148.7k | |
| Independent Director | 2.1yrs | US$260.01k | 0% $ 0 |
5.6yrs
Durata media
59yo
Età media
Consiglio di amministrazione esperto: NUVA's board of directors are considered experienced (5.6 years average tenure).